4-1BB co-stimulation enhances human CD8+ T cell priming by augmenting the proliferation and survival of effector CD8+ T cells

International Immunology

Volumn 14, Issue 10, 2002, Pages 1155-1167

  Laderach, Diego ^a,d   Movassagh, Mojgan ^a   Johnson, Anthony ^b   Mittler, Robert S ^c   Galy, Anne ^a,d  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

4 1BB; Co stimulation

Indexed keywords

CD8 ANTIGEN; CELL ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; LIGAND; MONOCLONAL ANTIBODY; OKT 3; PEPTIDE DERIVATIVE; PROTEIN BCL 2; PROTEIN BCL XL; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ACCESSORY CELL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; BLOOD CELL; CELL DEATH; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOTOXICITY; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR IMMUNITY; UMBILICAL CORD BLOOD; VIRUS IMMUNITY;

EID: 0036800027     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxf080     Document Type: Article

References (54)

1. Liu, Y. and Linsley, P. 1992. Costimulation of T-cell growth. Curr. Opin. Immunol. 4:265.
2. Sagerstrom, C., Kerr, E., Allison, J. and Davis, M. 1993. Activation and differentiation requirements of primary T cells in vitro. Proc. Natl Acad. Sci. USA 90:8987.
3. L. Immunity 3:87.
4. Yashiro-Ohtani, Y., Zhou, X., Toyo-oka, K., Tai, X., Park, C., Hamaoka, T., Abe, R,, Miyake, K. and Fujiwara, H. 2000. Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts. J. Immunol. 164:1251.
5. Dutton, R., Bradley, L. and Swain, S. 1998. T cell memory. Annu. Rev. Immunol. 16:201.
6. Johnson, J. and Jenkins, M. 1993. Accessory cell-derived signals required for T cell activation. Immunol. Res. 12:48.
7. + cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection. J. Virol. 72:7440.
8. Tan, J., Whitmire, J., Ahmed, R., Pearson, T. and Larsen, C. 1999. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J. Immunol. 163:4859.
9. Kwon, B. and Weissman, S. 1989. cDNA sequences of two inducible T-cell genes. Proc. Natl Acad. Sci. USA 86:1963.
10. Schwarz, H., Tuckwell, J. and Lotz, M. 1993. A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family. Gene 134:295.
11. lck1. J. Immunol. 151:1255.
12. Alderson, M., Smith, C., Tough, T., Davis-Smith, T., Armitage, R., Falk, B., Roux, E., Baker, E., Sutherland, G. and Din, W. 1994. Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol. 24:2219.
13. Zhou, Z., Kim, S., Hurtado, J., Lee, Z. H., Kim, K. K., Pollok, K. E. and Kwon, B. S. 1995. Characterization of human homologue of 41BB and its ligand. Immunol. Lett. 45:67.
14. DeBenedette, M., Shahinian, A., Mak, T. and Watts, T. 1997. Costimulation of CD28- T lymphocytes by 4-1BB ligand. J. Immunol. 158:551.
15. DeBenedette, M., Wen, T., Bachmann, M., Ohashi, P., Barber, B., Stocking, K., Peschon, J. and Watts, T. 1999. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J. Immunol. 163:4833.
16. Blazar, B., Kwon, B., Panoskaltsis-Mortari, A., Kwak, K., Peschon, J. and Taylor, P. 2001. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogenic bone marrow transplant recipients. J. Immunol. 166:3174.
17. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186:47.
18. Melero, I., Shuford, W., Newby, S., Aruffo, A., Ledbetter, J., Hellstrom, K., Mittler, R. and Chen, L. 1997. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med. 3:682.
19. Guinn, B., DeBenedette, M., Watts, T. and Berinstein, N. 1999. 41BBL cooperates with 137-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine. J. Immunol. 162:5003.
20. h-independent priming of CTL in the presence of an intact CD28 costimulatory pathway. J. Immunol. 168:3755.
21. Pollok, K., Kim, Y., Zhou, Z., Hurtado, J., Kim, K., Pickard, R. and Kwon, B. 1993. Inducible T cell antigen 4-1BB. Analysis of expression and function. J. Immunol. 150:771.
22. Melero, I., Johnston, J., Shufford, W., Mittler, R. and Chen, L. 1998. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-41BB monoclonal antibodies. Cell. Immunol. 190:167.
23. Schwarz, H., Valbracht, J., Tuckwell, J., von Kempis, J, and Lotz, M. 1995. ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages. Blood 85:1043.
24. Gramaglia, I., Cooper, D., Miner, K., Kwon, B. and Croft, M. 2000. Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand. Eur. J. Immunol. 30:392.
25. Cannons, J., Lau, P., Ghumman, B., DeBenedette, M., Yagita, H., Okumura, K. and Watts, T. 2001. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J. Immunol. 167:1313.
26. Hurtado, J., Kim, Y. and Kwon, B. 1997. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J. Immunol. 158:2600.
27. Saoulli, K., Lee, S., Cannons, J., Yeh, W., Santana, A., Goldstein, M., Bangia, N., DeBenedette, M., Mak, T., Choi, Y. and Watts, T. 1998. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med. 187:1849.
28. Takahashi, C., Mittler, R. and Vella, A. 1999. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 162:5037.
29. h1 cell responses. Eur. J. Immunol. 28:881.
30. Wen, Y., Bukczynski, J. and Watts, T. 2002. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production and the development of cytolytic effector function. J. Immunol. 168:4897.
31. Kim, Y., Mantel, P., June, C., Kim, S. and Kwon, B. 1999, 4-1BB costimulation promotes human T cell adhesion to fibronectin. Cell. Immunol. 192:13.
32. + T cells. J. Immunol. 163:3597.
33. Ferlazzo, G., Klein, J., Paliard, X., Wei, W. and Galy, A. 2000. Dendritic cells generated from CD34+ progenitor cells with flt3-ligand, c-kit-ligand, GM-CSF, IL-4 and TNF-α are functional antigen-presenting cells resembling mature monocyte-derived DC. J. Immunother. 23:48.
34. Kawashima, I., Hudson, S. J., Tsai, V., Southwood, S., Takesako, K., Appella, E., Sette, A. and Celis, E. 1998. The multi-epitope approach for immunotherapy for cancer: Identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors. Hum. Immunol 59:1.
35. + T cells. J. Exp. Med. 186:1407.
36. Michel, J. and Schwarz, H. 2000. Expression of soluble CD137 correlates with activation-induced cell death of lymphocytes. Cytokine 12:742.
37. hi transitional T cell in humans. Cell. Immunol. 169:91.
38. + T cells. J. Immunol. 165:1182.
39. Murali-Krishna, K., Altman, J., Suresh, M., Sourdive, D., Zajac, A., Miller, J., Slansky, J. and Ahmed, R. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177.
40. Boise, L., Gonzalez-Garcia, M., Postema, C,, Ding, L., Lindsten, T., Turka, L., Mao, X., Nunez, G. and Thompson, C. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597.
41. + T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation). Eur. J. Immunol. 24:859.
42. + T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity. J. Immunol. 163:3239.
43. + T cells during activation. J. Immunol. 164:4493.
44. Dubey, C., Croft, M. and Swain, S. 1996. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J. Immunol. 157:3280.
45. Schwartz, D., Wong, R., Chatila, T., Arnaout, A., Miller, R. and Geha, R. 1989. Proliferation of highly purified T cells in response to signaling via surface receptors requires cell-cell contact. J. Clin. Immunol. 9:151.
46. Boise, L., Minn, A., June, C., Lindsten, T. and Thompson, C. 1995. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc. Natl Acad. Sci. USA 92:5491.
47. Croft, M. 1994. Activation of naive, memory and effector T cells. Curr. Opin. Immunol. 6:431.
48. Inaba, K., Metlay, J., Crowley, M. and Steinman, R. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172:631.
49. Kundig, T., Shahinian, A., Kawai, K., Mittrucker, H., Sebzda, E., Bachmann, M., Mak, T. and Ohashi, P. 1996. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5:41.
50. Viola, A. and Lanzavecchia, A. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104.
51. Tan, J., Whitmire, J., Murali-Krishna, K., Ahmed, R., Altman, J., Mittler, R., Sette, A., Pearson, T. and Larsen, C. 2000. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. J. Immunol. 164:2320.
52. Lenardo, M. J. 1991. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858.
53. + memory T cells. J. Immunol. 165:3031.
54. Kim, J., Averbrook, B., Chambers, K., Rothchild, K., Kjaergaard, J., Papay, R. and Su, S. 2001. Divergent effects of 4-1BB antibodies on anti-tumor immunity and on tumor-reactive T-cell generation. Cancer Res. 61:2031.